447 related articles for article (PubMed ID: 22978843)
1. The spectrum of complications following left ventricular assist device placement.
Yuan N; Arnaoutakis GJ; George TJ; Allen JG; Ju DG; Schaffer JM; Russell SD; Shah AS; Conte JV
J Card Surg; 2012 Sep; 27(5):630-8. PubMed ID: 22978843
[TBL] [Abstract][Full Text] [Related]
2. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
[TBL] [Abstract][Full Text] [Related]
3. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
[TBL] [Abstract][Full Text] [Related]
4. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes.
Kormos RL; Teuteberg JJ; Pagani FD; Russell SD; John R; Miller LW; Massey T; Milano CA; Moazami N; Sundareswaran KS; Farrar DJ;
J Thorac Cardiovasc Surg; 2010 May; 139(5):1316-24. PubMed ID: 20132950
[TBL] [Abstract][Full Text] [Related]
5. Use of left ventricular assist device (HeartMate II): a Singapore experience.
Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
[TBL] [Abstract][Full Text] [Related]
6. Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices.
Patel ND; Weiss ES; Schaffer J; Ullrich SL; Rivard DC; Shah AS; Russell SD; Conte JV
Ann Thorac Surg; 2008 Sep; 86(3):832-40; discussion 832-40. PubMed ID: 18721570
[TBL] [Abstract][Full Text] [Related]
7. Effects of centrifugal, axial, and pulsatile left ventricular assist device support on end-organ function in heart failure patients.
Kamdar F; Boyle A; Liao K; Colvin-adams M; Joyce L; John R
J Heart Lung Transplant; 2009 Apr; 28(4):352-9. PubMed ID: 19332262
[TBL] [Abstract][Full Text] [Related]
8. Significance of postoperative acute renal failure after continuous-flow left ventricular assist device implantation.
Borgi J; Tsiouris A; Hodari A; Cogan CM; Paone G; Morgan JA
Ann Thorac Surg; 2013 Jan; 95(1):163-9. PubMed ID: 23103012
[TBL] [Abstract][Full Text] [Related]
9. Device exchange after primary left ventricular assist device implantation: indications and outcomes.
Stulak JM; Cowger J; Haft JW; Romano MA; Aaronson KD; Pagani FD
Ann Thorac Surg; 2013 Apr; 95(4):1262-7; discussion 1267-8. PubMed ID: 23063192
[TBL] [Abstract][Full Text] [Related]
10. Effects of pulsatile- and continuous-flow left ventricular assist devices on left ventricular unloading.
Garcia S; Kandar F; Boyle A; Colvin-Adams M; Lliao K; Joyce L; John R
J Heart Lung Transplant; 2008 Mar; 27(3):261-7. PubMed ID: 18342746
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology, management, and outcomes of sustained ventricular arrhythmias after continuous-flow left ventricular assist device implantation.
Raasch H; Jensen BC; Chang PP; Mounsey JP; Gehi AK; Chung EH; Sheridan BC; Bowen A; Katz JN
Am Heart J; 2012 Sep; 164(3):373-8. PubMed ID: 22980304
[TBL] [Abstract][Full Text] [Related]
12. Gastrointestinal bleeding with the HeartMate II left ventricular assist device.
Morgan JA; Paone G; Nemeh HW; Henry SE; Patel R; Vavra J; Williams CT; Lanfear DE; Tita C; Brewer RJ
J Heart Lung Transplant; 2012 Jul; 31(7):715-8. PubMed ID: 22425231
[TBL] [Abstract][Full Text] [Related]
13. Does continuous flow left ventricular assist device technology have a positive impact on outcome pretransplant and posttransplant?
Klotz S; Stypmann J; Welp H; Schmid C; Drees G; Rukosujew A; Scheld HH
Ann Thorac Surg; 2006 Nov; 82(5):1774-8. PubMed ID: 17062246
[TBL] [Abstract][Full Text] [Related]
14. Improved durability of the HeartMate XVE left ventricular assist device provides safe mechanical support up to 1 year but is associated with high risk of device failure in the second year.
Martin J; Friesewinkel O; Benk C; Sorg S; Schultz S; Beyersdorf F
J Heart Lung Transplant; 2006 Apr; 25(4):384-90. PubMed ID: 16563965
[TBL] [Abstract][Full Text] [Related]
15. Neurocognitive function in destination therapy patients receiving continuous-flow vs pulsatile-flow left ventricular assist device support.
Petrucci RJ; Rogers JG; Blue L; Gallagher C; Russell SD; Dordunoo D; Jaski BE; Chillcott S; Sun B; Yanssens TL; Tatooles A; Koundakjian L; Farrar DJ; Slaughter MS
J Heart Lung Transplant; 2012 Jan; 31(1):27-36. PubMed ID: 22153550
[TBL] [Abstract][Full Text] [Related]
16. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device.
John R; Kamdar F; Liao K; Colvin-Adams M; Miller L; Joyce L; Boyle A
J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1318-23. PubMed ID: 19026822
[TBL] [Abstract][Full Text] [Related]
17. Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure.
Dang NC; Topkara VK; Mercando M; Kay J; Kruger KH; Aboodi MS; Oz MC; Naka Y
J Heart Lung Transplant; 2006 Jan; 25(1):1-6. PubMed ID: 16399523
[TBL] [Abstract][Full Text] [Related]
18. Adverse events in contemporary continuous-flow left ventricular assist devices: A multi-institutional comparison shows significant differences.
Stulak JM; Davis ME; Haglund N; Dunlay S; Cowger J; Shah P; Pagani FD; Aaronson KD; Maltais S
J Thorac Cardiovasc Surg; 2016 Jan; 151(1):177-89. PubMed ID: 26545967
[TBL] [Abstract][Full Text] [Related]
19. Low incidence of neurologic events during long-term support with the HeartMate XVE left ventricular assist device.
Slaughter MS; Sobieski MA; Gallagher C; Dia M; Silver MA
Tex Heart Inst J; 2008; 35(3):245-9. PubMed ID: 18941649
[TBL] [Abstract][Full Text] [Related]
20. Impact of concurrent surgical valve procedures in patients receiving continuous-flow devices.
John R; Naka Y; Park SJ; Sai-Sudhakar C; Salerno C; Sundareswaran KS; Farrar DJ; Milano CA
J Thorac Cardiovasc Surg; 2014 Feb; 147(2):581-9; discussion 589. PubMed ID: 24418362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
